SCHEMBL4499250

SCHEMBL4499250

CC1c2cccn2-c2ccc(F)cc2N1S(=O)(=O)c1ccc(O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 7/20 0.43
PSEN2 P49810 7/20 0.43
APH1B Q8WW43 7/20 0.43
NCSTN Q92542 7/20 0.43
APH1A Q96BI3 7/20 0.43
PSENEN Q9NZ42 7/20 0.43
ESR1 P03372 1/20 0.40
PTPN2 P17706 1/20 0.37
PTPN1 P18031 1/20 0.37
MMP2 P08253 2/20 0.36
PTGS2 P35354 2/20 0.34
ALDH1A1 P00352 1/20 0.34
THRB P10828 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4491924 0.88 ESR1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4489791 0.87 PSEN1 (0.38) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4493610 0.86 ESR1 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4502313 0.86 MMP2 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4490135 0.81 MMP8 (0.38) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4498611 0.81 GAA (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4503272 0.76 KMT2A (0.43) PTPN2PTPN1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4501038 0.76 KMT2A (0.43) PTPN2PTPN1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4491393 0.76 KMT2A (0.43) PTPN2PTPN1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4508160 0.75 MMP2 (0.41) MMP2SMN1; SMN2NPSR1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160815-A1 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents WYETH (US) 2006-07-20 US claimed
US-7563793-B2 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents WYETH (US) 2009-07-21 US disclosed
US-20060160815-A1 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents WYETH (US) 2006-07-20 US disclosed
WO-2006068928-A1 PYRROLO[1,2-A]QUINOXALIN-5-(4H)-YL)SULFONYLS AND CARBONYLS AND THEIR USE AS ESTROGENIC AGENTS WYETH (US) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160815-A1 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents ESR1, GPER1, ESR2 PSEN1 3058/4885PSEN2 3454/4885APH1B 4249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.